中核科技(000777.SZ):擬於近期與關聯方共簽訂3份合同
格隆匯6月29日丨中核科技(000777.SZ)公佈,公司擬於近期在北京與關聯方中國核電工程有限公司(“核電工程公司”)簽訂2份合同,合同金額總計為人民幣2970.355萬元,具體如下:
(1)、《田灣核電站7、8號機組主給水隔離閥設備供貨合同》,根據合同協議約定,合同金額為1485.1775萬元,交貨期為2023年5月10日和2024年3月10日,分機組分批次交貨;
(2)、《徐大堡核電廠3、4號機組主給水隔離閥設備供貨合同》,根據合同協議約定,合同金額為1485.1775萬元,交貨期為2024年3月20日和2025年1月30日,分機組分批次交貨;
公司擬於近期在上海與關聯方中原運維海外工程有限公司(“中原運維公司”)簽訂1份合同,合同金額總計為人民幣1767.54642萬元,具體如下:
《C-3/C-4項目五年期備件採購訂貨合同-核級閘閥、核級節流閥備件》,根據合同協議約定,合同金額為1767.54642萬元,交貨期為2022年4月30日,分批次交貨。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.